LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.77 | 84.90 | 682 | 411 | 1.6584 | 1.4977 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.77 | 84.90 | 905 | 411 | 2.2007 | 1.8283 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.47 | 84.90 | 915 | 447 | 2.0450 | 1.6953 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.47 | 84.90 | 743 | 447 | 1.6606 | 1.4711 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 9.47 | 84.90 | 977 | 447 | 2.1836 | 1.7700 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 962 | 492 | 1.9539 | 1.6046 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 768 | 492 | 1.5598 | 1.3832 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 3 | 492 | 0.0061 | -0.7324 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 1060 | 492 | 2.1529 | 1.7062 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 996 | 531 | 1.8757 | 1.5369 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 814 | 531 | 1.5330 | 1.3506 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 38 | 531 | 0.0716 | -0.2621 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 1104 | 531 | 2.0791 | 1.6376 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1057 | 663 | 1.5933 | 1.3401 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | H20 |